Literature DB >> 28391784

Neuromyelitis Optica Spectrum Disorders.

Tetsuya Akaishi1, Ichiro Nakashima1, Douglas Kazutoshi Sato2, Toshiyuki Takahashi3, Kazuo Fujihara4.   

Abstract

Neuromyelitis optica (NMO) is clinically characterized by severe optic neuritis and transverse myelitis, but recent studies with anti-aquaporin-4-antibody specific to NMO have revealed that the clinical spectrum is wider than previously thought. International consensus diagnostic criteria propose NMO spectrum disorders (NMOSD) as the term to define the entire spectrum including typical NMO, optic neuritis, acute myelitis, brain syndrome, and their combinations. NMOSD is now divided into anti-aquaporin-4-antibody-seropositive NMOSD and -seronegative NMOSD (or unknown serostatus). MR imaging and optical coherence tomography are indispensable in the diagnosis and evaluation of NMOSD. This article reviews the clinical and MR imaging findings of anti-aquaporin-4-antibody-seropositive and anti-myelin oligodendrocyte glycoprotein-antibody-seropositive NMOSD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-aquaporin-4 antibody; Anti-myelin oligodendrocyte glycoprotein antibody; MR imaging; Neuromyelitis optica spectrum disorders; Optical coherence tomography

Mesh：

Substances：

Year:  2017        PMID： 28391784     DOI： 10.1016/j.nic.2016.12.010

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN： 1052-5149            Impact factor:   2.264


  14 in total

Review 1.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

Review 2.  Autoimmune disease of head and neck, imaging, and clinical review.

Authors:  Alireza Paydar; Zachary B Jenner; Tyrell J Simkins; Yu-Ming Chang; Lotfi Hacein-Bey; Arzu Ozturk; Andrew Birkeland; Reza Assadsangabi; Osama Raslan; Ghazal Shadmani; Michelle Apperson; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2022-05-22

3.  Correlation between ERα gene polymorphism and multiple sclerosis and neuromyelitis optica.

Authors:  Weifang Xing; Mingfan Hong; Zhisheng Wei; Wensheng Zhang
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 4.  Optic neuropathy as a presenting feature of vitamin B-12 deficiency: A systematic review of literature and a case report.

Authors:  Fateen Ata; Ammara Bint I Bilal; Saad Javed; Hammad Shabir Chaudhry; Rohit Sharma; Rubab Fatima Malik; Hassan Choudry; Anand Bhaskaran Kartha
Journal:  Ann Med Surg (Lond)       Date:  2020-11-05

5.  Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Authors:  Lawrence J Cook; John W Rose; Jessica S Alvey; Anna Marie Jolley; Renee Kuhn; Brie Marron; Melissa Pederson; Rene Enriquez; Jeff Yearley; Stephen McKechnie; May H Han; Anna J Tomczak; Michael Levy; Maureen A Mealy; Jessica Coleman; Jeffrey L Bennett; Ruth Johnson; Myka Barnes-Garcia; Anthony L Traboulsee; Robert L Carruthers; Lisa Eunyoung Lee; Julia J Schubert; Katrina McMullen; Ilya Kister; Zoe Rimler; Allyson Reid; Nancy L Sicotte; Sarah M Planchon; Jeffrey A Cohen; Diane Ivancic; Jennifer L Sedlak; Ilana Katz Sand; Pavle Repovic; Lilyana Amezcua; Ana Pruitt; Erika Amundson; Tanuja Chitnis; Devin S Mullin; Eric C Klawiter; Andrew W Russo; Claire S Riley; Kaho B Onomichi; Libby Levine; Katherine E Nelson; Nancy M Nealon; Casey Engel; Mason Kruse-Hoyer; Melanie Marcille; Leticia Tornes; Anne Rumpf; Angela Greer; Megan Kenneally Behne; Renee R Rodriguez; Daniel W Behne; Derek W Blackway; Brian Coords; Terrence F Blaschke; Judy Sheard; Terry J Smith; Jacinta M Behne; Michael R Yeaman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-28

6.  Neuromyelitis optica spectrum disorder: Patient experience and quality of life.

Authors:  Janine Beekman; Aysha Keisler; Omar Pedraza; Masayuki Haramura; Athos Gianella-Borradori; Eliezer Katz; John N Ratchford; Gerard Barron; Lawrence J Cook; Jacinta M Behne; Terrence F Blaschke; Terry J Smith; Michael R Yeaman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-20

7.  Late Onset of Neuromyelitis Optica Spectrum Disorders.

Authors:  Yara Dadalti Fragoso; Heloisa Helena Ruocco; Ronaldo Maciel Dias; Hideraldo Cabeça; Ricardo Gonçalves; Nise A de Carvalho Sousa; Caroline Vieira Spessotto; Carlos Bernardo Tauil; Soniza Vieira Alves-Leon; Sidney Gomes; Marcus Vinicius M Gonçalves; Suzana C Nunes Machado; Andrea Anacleto; Eber Castro Correa; Maria Lucia V Pimentel; Gutemberg Augusto C Santos
Journal:  Neurol Ther       Date:  2019-07-02

8.  Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome.

Authors:  Shripad S Pujari; Rahul V Kulkarni; Dattatraya B Nadgir; Pawan K Ojha; Shashank Nagendra; Vikram Aglave; Rashmi D Nadgir; Hemant Sant; Nilesh Palasdeokar; Satish Nirhale; Sunil Bandishti
Journal:  Ann Indian Acad Neurol       Date:  2020-03-03       Impact factor: 1.383

9.  Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis.

Authors:  Sanjeev Kharel; Suraj Shrestha; Rajeev Ojha; Neha Guragain; Rakesh Ghimire
Journal:  BMC Neurol       Date:  2021-11-23       Impact factor: 2.474

Review 10.  Cognitive impairment in NMOSD-More questions than answers.

Authors:  Dominika Czarnecka; Magdalena Oset; Iwona Karlińska; Mariusz Stasiołek
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.